| Not Yet Recruiting | Efficacy and Safety of IL-1 Inhibitors in Mild to Moderate Systemic Lupus Erythematosus Lupus Erythematosus, Systemic | Phase 4 | 2026-04-15 |
| Not Yet Recruiting | Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active Takayasu's Arteritis Takayasu Arteritis (TAK) | Phase 4 | 2026-04-01 |
| Not Yet Recruiting | The Efficacy and Safety of Deucravacitinib in Takayasu's Arteritis Takayasu Arteritis (TAK) | Phase 4 | 2025-06-15 |
| Not Yet Recruiting | Telitacicept for the Treatment of Refractory RA Rheumatoid Arthritis (RA) | Phase 4 | 2025-06-10 |
| Recruiting | Vunakizumab for the Treatment of Mild to Moderate Systemic Lupus Erythematosus Lupus Erythematosus, Systemic | Phase 1 | 2025-05-19 |
| Recruiting | Chinese Rheumatism Biobank(CRB) Lupus Erythematosus, Systemic | — | 2025-02-10 |
| Not Yet Recruiting | A Study on the Prevention and Treatment of GIOP With Eldecalcitol Rheumatoid Arthritis, Osteoporosis, Osteopenia | Phase 4 | 2024-06-01 |
| Recruiting | Exploring Biomarkers for Therapeutic Response of Lupus Nephritis Based on Multi Omics Analysis Lupus Nephritis | — | 2023-12-05 |
| Unknown | Bortezomib for the Treatment of Refractory Rheumatoid Arthritis Rheumatoid Arthritis | N/A | 2023-12-01 |
| Recruiting | Effectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in Systemic Lupus Erythem Systemic Lupus Erythematosus, Lupus Nephritis | Phase 4 | 2023-07-01 |
| Recruiting | Efficacy and Safety for Rituximab Combined With Telitacicept in the Treatment of ANCA-associated Vasculitis (T ANCA Associated Vasculitis | Phase 4 | 2023-06-29 |
| Unknown | Anti-CD20 Antibodies for Treatment of SLE-PAH Systemic Lupus Erythematosus, Pulmonary Arterial Hypertension | Phase 4 | 2023-05-25 |
| Recruiting | Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTC ANCA-associated Vasculitis, Maintenance Therapy | Phase 4 | 2023-03-09 |
| Unknown | Comparison of Tofacitinib and Prednisolone in the Treatment of Active Takayasu's Arteritis Takayasu Arteritis | Phase 3 | 2023-01-20 |
| Unknown | Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis Takayasu Arteritis | Phase 4 | 2022-01-05 |
| Unknown | Comparison of the Efficacy of Leflunomide and Azathioprine for the Maintenance Therapy of ANCA Associated Vasc ANCA Associated Vasculitis, Maintenance Therapy | N/A | 2021-06-30 |
| Active Not Recruiting | Efficacy and Safety of Sirolimus in Active Systemic Lupus Erythematosus Systemic Lupus Erythematosus | Phase 3 | 2021-03-04 |
| Completed | The Survey of Satisfaction in Chinese Rheumatologists and Patients With Rheumatoid Arthritis Rheumatoid Arthritis, Satisfaction | — | 2018-03-31 |
| Completed | Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis Takayasu Arteritis | Phase 3 | 2017-03-16 |
| Unknown | Kunxian for the Treatment of Rheumatoid Arthritis Rheumatoid Arthritis | Phase 4 | 2015-09-01 |
| Terminated | Cyclophosphamide and Hydroxychloroquine for Thrombocytopenia in SLE Thrombocytopenia | Phase 3 | 2015-07-01 |